🎉 M&A multiples are live!
Check it out!

Lundbeck Valuation Multiples

Discover revenue and EBITDA valuation multiples for Lundbeck and other public comps.

See Lundbeck Valuation Multiples

Lundbeck Overview

About Lundbeck

Lundbeck is a Denmark-based pharmaceutical firm that focuses on the development and commercialization of central nervous system drugs including antidepressants, antipsychotics, and antiepileptic products. The company’s portfolio includes Abilify Maintena and Rexulti for psychosis, Brintellix/Trintellix for depression, Northera for Parkinson’s disease symptoms, Sabril and Onfi for seizures, and Vyepti for migraine prevention. Most of the company's sales are derived in North America, followed by Asia and Europe.


Founded

1915

HQ

Denmark
Employees

5.7K+

Website

lundbeck.com

Financials

LTM Revenue n/a

LTM EBITDA n/a

EV

$7.3B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Lundbeck Financials

Lundbeck has a last 12-month revenue of n/a and a last 12-month EBITDA of n/a.

In the most recent fiscal year, Lundbeck achieved revenue of $3.1B and an EBITDA of $797M.

Lundbeck expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Lundbeck valuation multiples based on analyst estimates

Lundbeck P&L

FY 2022 FY 2023 FY 2024 LTM NTM
Revenue $2.5B $2.8B $3.1B n/a XXX
Gross Profit $2.0B $2.2B $2.5B XXX XXX
Gross Margin 78% 77% 81% XXX XXX
EBITDA $613M $707M $797M n/a XXX
EBITDA Margin 24% 25% 26% NaN% XXX
Net Profit $268M $320M $439M XXX XXX
Net Margin 11% 12% 14% XXX XXX
Net Debt $234M n/a $1.6B XXX XXX

Financial data powered by Morningstar, Inc.

Lundbeck Stock Performance

As of February 10, 2025, Lundbeck's stock price is DKK 41 (or $6).

Lundbeck has current market cap of DKK 40.3B (or $5.6B), and EV of DKK 52.3B (or $7.3B).

See Lundbeck trading valuation data

Lundbeck Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$7.3B $5.6B XXX XXX XXX XXX n/a

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Lundbeck Valuation Multiples

As of February 10, 2025, Lundbeck has market cap of $5.6B and EV of $7.3B.

Lundbeck's trades at n/a LTM EV/Revenue multiple, and n/a LTM EBITDA.

Analysts estimate Lundbeck's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Lundbeck and 10K+ public comps

Lundbeck Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $7.3B XXX XXX XXX
EV/Revenue n/a XXX XXX XXX
EV/EBITDA n/a XXX XXX XXX
P/E n/a XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF n/a XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Lundbeck Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Lundbeck Valuation Multiples

Lundbeck's NTM/LTM revenue growth is n/a

Lundbeck's revenue per employee for the last fiscal year averaged $0.5M, while opex per employee averaged $0.4M for the same period.

Over next 12 months, Lundbeck's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Lundbeck's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Lundbeck and other 10K+ public comps

Lundbeck Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 11% XXX XXX XXX XXX
EBITDA Margin n/a XXX XXX XXX XXX
EBITDA Growth 13% XXX XXX XXX XXX
Rule of 40 (SaaS-only) n/a XXX XXX XXX XXX
Revenue per Employee $0.5M XXX XXX XXX XXX
Opex per Employee $0.4M XXX XXX XXX XXX
S&M Expenses to Revenue 37% XXX XXX XXX XXX
G&A Expenses to Revenue 7% XXX XXX XXX XXX
R&D Expenses to Revenue 20% XXX XXX XXX XXX
Opex to Revenue 66% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Medical Devices
Consumer SaaS
Streaming Platforms
AdTech Software
Climate Tech
GRC Software
Developer Tools

Lundbeck Public Comps

See valuation multiples for Lundbeck public comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Lundbeck M&A and Investment Activity

Lundbeck acquired  XXX companies to date.

Last acquisition by Lundbeck was  XXXXXXXX, XXXXX XXXXX XXXXXX . Lundbeck acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Lundbeck

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Lundbeck

When was Lundbeck founded? Lundbeck was founded in 1915.
Where is Lundbeck headquartered? Lundbeck is headquartered in Denmark.
How many employees does Lundbeck have? As of today, Lundbeck has 5.7K+ employees.
Is Lundbeck publicy listed? Yes, Lundbeck is a public company listed on CSE.
What is the stock symbol of Lundbeck? Lundbeck trades under HLUN A ticker.
When did Lundbeck go public? Lundbeck went public in 2022.
Who are competitors of Lundbeck? Similar companies to Lundbeck include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics.
What is the current market cap of Lundbeck? Lundbeck's current market cap is $5.6B
What is the current revenue growth of Lundbeck? Lundbeck revenue growth between 2023 and 2024 was 11%.
Is Lundbeck profitable? Yes, Lundbeck is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.